Figure 3.
Correlation between plasma concentration of rivaroxaban and inhibition of Factor Xa (FXa) activity (A) and prothrombin time (PT) (B) after administration of single and multiple doses of rivaroxaban
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.